Insider Transactions in Q2 2020 at Zynex Inc (ZYXI)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,482
-9.48%
|
$31,122
$21.43 P/Share
|
|
Jun 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.96%
|
-
|
|
May 20
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+10.87%
|
-
|
|
May 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,750
-26.09%
|
$67,500
$18.99 P/Share
|
|
May 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,021
+4.02%
|
-
|
|
Apr 30
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-30.88%
|
$510,000
$17.33 P/Share
|
|
Apr 29
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
50,000
-0.36%
|
$850,000
$17.1 P/Share
|
|
Apr 28
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
19,817
-0.14%
|
$317,072
$16.1 P/Share
|
|
Apr 27
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
30,183
-0.22%
|
$482,928
$16.11 P/Share
|
|
Apr 24
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
25,143
-0.18%
|
$377,145
$15.1 P/Share
|
|
Apr 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+10.0%
|
-
|